SCHEMBL6512180

SCHEMBL6512180

C=C1[C@@H]2CC[C@@H](C2)[C@@]1(C)CC/C=C(\C)CO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 3/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19156831 1.00 CNR2 (1.00) CNR2
SCHEMBL11453769 1.00 CNR2 (1.00) CNR2
SCHEMBL18727654 1.00 CNR2 (1.00) CNR2
SCHEMBL10980549 1.00 CNR2 (1.00) CNR2
SCHEMBL1838672 1.00 CNR2 (1.00) CNR2
SCHEMBL654806 1.00 CNR2 (1.00) CNR2
SCHEMBL11360997 1.00 CNR2 (1.00) CNR2
SCHEMBL11398192 1.00 CNR2 (1.00) CNR2
SCHEMBL22362385 1.00 CNR2 (1.00) CNR2
SCHEMBL19155994 1.00 CNR2 (1.00) CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112176000-B Method for producing aromatic alcohols 弗门尼舍有限公司 2024-09-10 CN claimed
US-20240287478-A1 ARTIFICIAL ALKANE OXIDATION SYSTEM FOR ALLYLIC OXIDATION OF A TERPENE SUBSTRATE ISOBIONICS B.V. (NL) 2024-08-29 US claimed
EP-4381086-A1 ARTIFICIAL ALKANE OXIDATION SYSTEM FOR ALLYLIC OXIDATION OF A TERPENE SUBSTRATE Isobionics B.V. (NL) 2024-06-12 EP claimed
CN-117795088-A Artificial alkane oxidation system for allyl oxidation of terpene substrates 艾瑟拜奥尼克斯公司 2024-03-29 CN claimed
WO-2023012370-A1 ARTIFICIAL ALKANE OXIDATION SYSTEM FOR ALLYLIC OXIDATION OF A TERPENE SUBSTRATE ISOBIONICS B.V. (NL) 2023-02-09 WO claimed
US-20260034186-A1 ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS RIZUN NODARI (US) 2026-02-05 US disclosed
US-20260027136-A1 CANNABIS BASED THERAPEUTIC AND METHOD OF USE YUZU LV LLC (US) 2026-01-29 US disclosed
US-12458653-B2 Cannabis based therapeutic and method of use YUZU LV LLC (US) 2025-11-04 US disclosed
US-12427176-B2 Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products RIZUN NODARI (US) 2025-09-30 US disclosed
US-12421535-B2 Biochemically produced sandalwood oil FIRMENICH SA (CH) 2025-09-23 US disclosed
US-12303488-B2 Cannabis based therapeutic and method of use YUZU LV LLC (US) 2025-05-20 US disclosed
CN-112176000-B Method for producing aromatic alcohols 弗门尼舍有限公司 2024-09-10 CN disclosed
US-20140213818-A1 PROCESS FOR THE PREPARATION OF BETA-SANTALOL FIRMENICH SA (CH) 2014-07-31 US disclosed
US-20140187811-A1 PROCESS FOR THE PREPARATION OF BETA-SANTALOL FIRMENICH SA (CH) 2014-07-03 US disclosed
US-20140187811-A1 PROCESS FOR THE PREPARATION OF BETA-SANTALOL FIRMENICH SA (CH) 2014-07-03 US disclosed
WO-2013001026-A1 PROCESS FOR THE PREPARATION OF BETA-SANTALOL FIRMENICH SA (CH) 2013-01-03 WO disclosed
WO-2013001027-A1 PROCESS FOR THE PREPARATION OF BETA-SANTALOL FIRMENICH SA (CH) 2013-01-03 WO disclosed
WO-2005087181-A2 DRY DEODORANT CONTAINING A SESQUITERPENE ALCOHOL AND ZINC OXIDE COLGATE-PALMOLIVE COMPANY (US) 2005-09-22 WO disclosed
US-20050191257-A1 Dry deodorant containing a sesquiterpene alcohol and zinc oxide COLGATE-PALMOLIVE COMPANY 2005-09-01 US disclosed
US-4510319-A ROGANOLEPTICS FRITZSCHE DODGE & OLCOTT INC. (US) 1985-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140213818-A1 PROCESS FOR THE PREPARATION OF BETA-SANTALOL ACSL3, ACSL1, CSNK1A1L CNR2 618/4885
US-20050191257-A1 Dry deodorant containing a sesquiterpene alcohol and zinc oxide FDFT1, SLC30A6, SLC30A7 CNR2 3780/4885
US-20140187811-A1 PROCESS FOR THE PREPARATION OF BETA-SANTALOL ACSL3, ACSL1, CSNK1A1L CNR2 751/4885
US-20260027136-A1 CANNABIS BASED THERAPEUTIC AND METHOD OF USE CNR1, CNR2, OPRM1 CNR2 2/4885
US-20260034186-A1 ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS TRPV1, SOST, RUNX1 CNR2 9/4885
US-20240287478-A1 ARTIFICIAL ALKANE OXIDATION SYSTEM FOR ALLYLIC OXIDATION OF A TERPENE SUBSTRATE HADH, ACOX1, COASY CNR2 3058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.